Crizotinib Continuation Clinical Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Crizotinib Continuation Clinical Study	Granuloma, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, T-cell non-Hodgkin lymphoma, Thoracic Neoplasms, anaplastic large cell lymphoma, bronchial neoplasm, bronchogenic carcinoma, immune system disorder, immunoproliferative disorder, inflammatory myofibroblastic tumor, lung disorder, lung neoplasm, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 4	2026-03-30		NCT05160922

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Pfizer	431

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
ASST Monza	Monza	Italy	1
Beijing Cancer Hospital	Beijing	China	208
Cancer Hospital Chinese Academy of Medical Science	Beijing	China	19
Fujian Province Oncology Hospital	Fuzhou	China	1
Jilin Cancer Hospital	Changchun	China	3
Limited Liability Company "EuroCityClinic"	Saint Petersburg	Russia	2
National Hospital Organization Nagoya Medical Center	Nagoya	Japan	8
National Taiwan University Hospital	Taipei	Taiwan	174
Shanghai Chest Hospital	Shanghai	China	33
Sun Yat-sen University Cancer Center	Guangzhou	China	315
The First Affiliated Hospital of College of Medicine,Zhejiang University	Hangzhou	China	1
The First Affiliated Hospital of Guangzhou Medical University.	Guangzhou	China	1
West China Hospital of Sichuan University	Wuhou District	China	1